EU expansion: Enlarged horizons or false dawn?

Nature Biotechnology

Volumn 22, Issue 5, 2004, Pages 501-504

  Sansom, Clare ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CRYSTALLOGRAPHY; EUROPEAN UNION; FINANCIAL MANAGEMENT; HISTORY OF MEDICINE; HUNGARY; POLAND; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW;

EMIGRATION AND IMMIGRATION; EUROPEAN UNION; SCIENCE;

EID: 2342580742     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0504-501     Document Type: Review

References (7)

1. Sansom, C. European biotechnology turns east. Nat. Biotechnol. 17, 437-439 (1999).
2. Dickson, D. et al. What next for science in Central Europe. Nature 372, 591-592 (1994).
3. European Commission Directorate-General for Research. Towards a European Research Area Science, Technology, Innovation (European Commission, Brussels, Belgium, 2003).
4. European Commission. Eurobarometer 2003. 4. Public Opinion in the Candidate Countries (European Commission, Brussels, Belgium, 2004).
5. Petition for a new and ambitious European science policy (European Life Scientist Organization, posted February 24, 2004). http://ultr23.vub.ac.be/petition/
6. Vanecek, J. Pharmacy and biotechnology in the Czech Republic. http://www.tc.cz/dokums/biotechnology_in_ czech9uk-revision_1100_1.pdf
7. Ernst and Young, Beyond Borders, The Global Biotechnology Report, 2002 (Ernst and Young, New York, June 2002).